CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses New Subsidiaries, Intellectual Property in Interview on Uptick Newswire’s Stock Day Podcast
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator that has developed and out-licenses its disruptive delivery technology, was recently featured on Uptick Newswire’s Stock Day Podcast. Chairman of the Board and CEO Chris Bunka provided an update regarding Lexaria’s licenses and technology. “Lexaria has been somewhat of a pioneer in this aspect of the business. We have been beating the drum on intellectual property since we began in 2014,” Bunka stated in the interview. “We now have over 50 patents outstanding in over 40 countries around the world. Our IP suite is one of the biggest and…